جاهز للتشغيل
جاهز للتشغيل
Non-alcoholic fatty liver disease associated with metabolic dysregulation (MASLD) can affect individuals with normal weight, with estimates indicating that 10-20% of cases occur in lean people. The disease remains a concern due to the accumulation of visceral fat around internal organs and insulin resistance, which can lead to liver health deterioration and an increased risk of mortality. The condition is not solely linked to obesity; therefore, monitoring indicators such as waist circumference, lipid levels, and blood sugar is recommended. Early diagnosis through screenings is important to prevent disease progression. Treatment involves lifestyle modifications, regular exercise, and reducing intake of sugars and processed foods, with an emphasis on managing metabolic risk factors to protect the liver.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading